Quantcast
Tag archive for ‘vaccines’
By Robert On Wednesday, November 27th, 2013
1 Comment

FDA study looks at pertussis vaccines and rising rates of whooping cough

A new study is helping to provide a better understanding of vaccines for whooping cough, the common name for the disease pertussis. Based on an animal model, the study conducted by the U.S. Food and Drug Administration More...

By Robert On Tuesday, November 26th, 2013
2 Comments

Princeton announces dates for receiving meningitis B vaccine

The New Jersey university, which has experienced eight cases of  serogroup B meningococcal disease since March, has announced the dates they will be administering the vaccine that helps protect against meningococcal More...

By Robert On Monday, November 25th, 2013
2 Comments

Inovio’s MERS vaccine, SynCon DNA vaccine, induces ‘robust and durable immune responses’ in pre-clinical testing

Inovio Pharmaceuticals, Inc. announced recently that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, More...

By Robert On Saturday, November 23rd, 2013
2 Comments

What is Bexsero? How common is meningococcal disease serogroup B?

With the eighth case of meningococcal meningitis confirmed at Princeton University yesterday, and at least seven confirmed as Neisseria meningitis serotype B (MenB) with the most recent still pending, health officials More...

By Robert On Friday, November 22nd, 2013
2 Comments

FDA approves H5N1 avian influenza vaccine for National Stockpile

The U.S. Food and Drug Administration today approved the first adjuvanted vaccine for the prevention of H5N1 influenza, commonly known as avian or bird flu. The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, More...

By Robert On Saturday, November 16th, 2013
2 Comments

Princeton considers the use of Bexsero meningitis vaccine to curb spread of meningitis B

Following the seventh confirmed case of Neisseria meningitis B infection at Princeton University since March, the school is considering the use of a European Union/Australia -approved vaccine that will protect against More...

By Robert On Tuesday, November 12th, 2013
1 Comment

Themis Bioscience Chikungunya vaccine in clinical trials

Viennese biotech company Themis Bioscience announced the start of a phase I clinical study on its Chikungunya fever vaccine. The vaccine candidate, which is based on a standard anti-measles vaccine, will be evaluated More...

By Robert On Monday, November 11th, 2013
2 Comments

Herpes simplex vaccine candidate clinical trial launched

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced the launch of phase 1 clinical trials into an investigational genital herpes vaccine, More...

By Robert On Wednesday, October 9th, 2013
2 Comments

Japanese encephalitis vaccine from China gets WHO stamp of approval

A Japanese encephalitis (JE) vaccine manufactured in China has be prequalified by the World Health Organization (WHO) becoming the first Chinese-produced vaccine to receive this status. Ochlerotatus japonicusImage/CDC The More...

By Robert On Saturday, October 5th, 2013
0 Comments

Investigational Norovirus vaccine reduces symptoms by more than 50 percent

An investigational vaccine appears generally well tolerated and effective against the most common strain of norovirus, reducing the main symptoms of the gastrointestinal (GI) infection, vomiting and/or diarrhea, More...

By Robert On Saturday, October 5th, 2013
0 Comments

Advanced BioScience Laboratories chosen to help develop Shigella vaccine candidate

Advanced BioScience Laboratories, Inc. (ABL), a biomedical contract research and manufacturing organization to the biotechnology and pharmaceutical industries, announced earlier this week that it has been selected More...

By Robert On Saturday, September 28th, 2013
0 Comments

WHO advises on H7N9 strain for vaccine development

The World Health Organization (WHO) has recommended a specific strain of avian influenza A(H7N9) to be used in the development of a H7N9 vaccine for pandemic purposes, according to a statement Thursday. This negatively-stained More...

By Robert On Wednesday, September 18th, 2013
1 Comment

H7N9 avian influenza vaccine candidate in clinical trials: NIH

Researchers at nine sites nationwide have begun testing in humans an investigational H7N9 avian influenza vaccine, according to a National Institutes of Health (NIH) news release today. This diagram depicts the More...

By Robert On Saturday, September 14th, 2013
2 Comments

MenAfriVac meningitis vaccine an incredible success in Chad

A new meningitis vaccine, MenAfriVac or PsA-TT, has proved to be a raging success in after a mass vaccination campaign in the African country of Chad, according to new research published in The Lancet. MenAfriVac,  a More...

By Robert On Saturday, September 7th, 2013
2 Comments

PaxVax Initiates Phase 3 Clinical Trial Challenge Studies for Single-Dose Oral Cholera Vaccine

PRESS RELEASE Menlo Park, Calif., – September 6, 2013 – PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it More...

By Robert On Tuesday, September 3rd, 2013
0 Comments

Imaxio’s IMX313 pro-immunogenic technology used in tuberculosis vaccine human clinical trial

Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis More...

By Robert On Sunday, August 18th, 2013
1 Comment

FDA approves FluLaval Quadrivalent influenza vaccine for persons three years and older

Pharmaceutical, biologics and vaccine company, GlaxoSmithKline (GSK), announced Friday that the Food and Drug Administration (FDA) has approved FluLaval Quadrivalent influenza vaccine for the active immunization More...

By Robert On Thursday, August 15th, 2013
1 Comment

CVS/pharmacy survey shows that six out of 10 people consider getting the flu shot a ‘social responsibility’

A new survey from CVS/pharmacy released today found that less than half of those surveyed (46%) were more likely to get a flu shot this year following last season’s late flu outbreak. But many more – 59% More...

By Robert On Monday, August 5th, 2013
0 Comments

FDA approves Menveo quadrivalent meningococcal vaccine in children starting as early as two months

The Food and Drug Administration (FDA) approved the expanded age range for Menveo quadrivalent meningococcal vaccine for infants and toddlers from 2 months of age, according to a FDA approval letter. Neisseria More...

By Robert On Thursday, July 25th, 2013
0 Comments

CDC gives update on HPV vaccination: ‘We’re dropping the ball’

During a Centers for Disease Control and Prevention (CDC) telebriefing today, health leaders gave an update on vaccination rates against human papillomavirus (HPV) and vaccine safety. CDC Director Thomas Frieden CDC More...

like_us_on_facebook

 

The Global Dispatch Facebook page- click here

Movie News Facebook page - click here

Television News Facebook page - click here

Weird News Facebook page - click here 

DISPATCH RADIO

dispatch_radio

THE BRANDON JONES SHOW

brandon_jones_show-logo

Categories